...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of substance abuse treatment >Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic
【24h】

Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic

机译：使用在Covid-19大流行的第一波浪潮中使用药物的人们增加艾滋病毒检测

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

People who use drugs (PWUD) often experience barriers to preventative health care. During the COVID-19 pandemic, due to lapses in harm reduction services, several public health experts forecasted subsequent increases in diagnosis of HIV in PWUD. As many inpatient hospitals reworked patient flow during the COVID-19 surge, we hypothesized that HIV testing in PWUD would decrease. To answer this question, we compiled a deidentified list of hospitalized patients with electronic medical record indicators of substance use?a positive urine toxicology screen, prescribed medications to treat opioid use disorder, a positive CIWA score, or a positive CAGE score?admitted between January, 2020 and August, 2020. The outcome of interest was HIV test completion during inpatient hospitalization. The study used logistic regression to examine associations between type of substance use and receipt of HIV test. The study grouped substance use type into four groups (1) opioids (oxycodone, fentanyl, or other opiates) or opioid use disorder treatments (methadone, buprenorphine, naltrexone); (2) stimulant use (cocaine or amphetamines); (3) alcohol use (presence of a positive CAGE or CIWA score or alcohol present on toxicology screen); and (4) benzodiazepine use (benzodiazepines present on toxicology screen). The proportion of PWUD who were tested for HIV increased from 10.4% in January, 2020 to 28.2% in April, 2020 and back down to 12% in August. Notably, there was an inverse trend over time for number of people hospitalized with drug use, from 259 in January to a nadir of 85 in April, and then up to 217 in August, 2020. Contrary to our hypothesis, HIV testing increased during the COVID-19 pandemic, and we discuss explanations for this finding. The decrease in HIV testing post-pandemic peak is a reminder that we must work to develop interventions that lead to sustained high rates of HIV testing for all people, and especially for PWUD.
机译：使用药物（PWUD）的人经常会遇到预防性保健的障碍。在2019冠状病毒疾病流行期间，由于减少了危害服务，一些公共卫生专家预测PWUD艾滋病的诊断将继续增加。在2019冠状病毒疾病的流行期间，许多住院医院重新设计了患者流动，我们假设PDWD中的HIV检测会减少。为了回答这个问题，我们编制了一份身份不明的住院患者名单，其中有药物使用的电子病历指标？尿液毒理学筛查阳性，治疗阿片类药物使用障碍的处方药，CIWA评分阳性，还是CAGE评分阳性？在2020年1月至2020年8月期间入学。令人感兴趣的结果是在住院期间完成HIV检测。这项研究使用逻辑回归来检验药物使用类型和接受HIV检测之间的关联。该研究将药物使用类型分为四组（1）阿片类药物（羟考酮、芬太尼或其他阿片类药物）或阿片类药物使用障碍治疗（美沙酮、丁丙诺啡、纳曲酮）；（2） 兴奋剂使用（可卡因或安非他明）；（3） 酒精使用（CAGE或CIWA评分呈阳性，或毒理学屏幕上显示酒精）；（4）苯二氮卓类药物的使用（毒理学筛查中的苯二氮卓类药物）。接受HIV检测的PWUD比例从2020年1月的10.4%上升到2020年4月的28.2%，并在8月回落到12%。值得注意的是，随着时间的推移，因吸毒住院的人数呈相反趋势，从1月的259人上升到4月的85人的最低点，然后在2020年8月上升到217人。与我们2019冠状病毒疾病的流行性试验相反，我们讨论了这一发现的解释。大流行后艾滋病毒检测高峰的减少提醒我们，我们必须努力制定干预措施，使所有人，尤其是普华永道人群的艾滋病毒检测率保持在较高水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号